Книги
  • @
  • «»{}∼
Strategies for Biotechnology Venture Capital 2008/2009: Top VCs and CEOs on Spotting Investments, Raising Capital, Establishing Valuations, and Evaluating Exit Options (Inside the Minds)

Strategies for Biotechnology Venture Capital 2008/2009: Top VCs and CEOs on Spotting Investments, Raising Capital, Establishing Valuations, and Evaluating Exit Options (Inside the Minds)

4155259
Добавить в корзину
Описание
Strategies for Biotechnology Venture Capital 2008/2009 is an authoritative, insider's perspective securing venture capital and achieving growth in the biotech industry for VCs, entrepreneurs, and industry executives. Featuring managing partners at top VC firms and CEOs of funded biotech companies, these experts provide key strategies for all stages of an investment with a focus on raising capital, establishing valuations, determining exit strategies, and structuring deals. From spotting opportunities and evaluating potential ROI to increasing fundraising and growing the company, these specialists offer strategies for building a management team, assessing potential exit scenarios, and navigating market opportunities. These seasoned experts reveal their advice for setting goals, mitigating risks, and avoiding common pitfalls. Additionally, the authors offer strategies for early-stage investing, determining M&A vs. IPO, and forecasting competitive technologies. The different niches presented and the breadth of perspectives represented enable readers to get inside some of leading minds of today, as these insiders offer up their thoughts around the keys to successful deal-making in this ever-evolving industry. Inside the Minds provides readers with proven business intelligence from C-Level executives (Chairman, CEO, CFO, CMO, Partner) from the world's most respected companies nationwide, rather than third-party accounts from unknown authors and analysts. Each chapter is comparable to an essay/thought leadership piece and is a future-oriented look at where an industry, profession or topic is headed and the most important issues for the future. Through an exhaustive selection process, each author was hand-picked by the Inside the Minds editorial board to author a chapter for this book. Chapters Include: 1. Dinesh Patel, Ph.D., Managing Director, vSpring Capital "Successful Valuations and Exits for Biotech Companies" 2. Killu Tougu Sanborn, Ph.D., Managing Director, Hercules Technology Growth Capital "Investing in Life Science Innovation: Debt versus Equity Investment Philosophy and Practical Tips for Both" 3. Fred A. Middleton, Managing Director, Sanderling Ventures "Early-Stage Venture Capital Investing in Biomedical Companies" 4. Ivor Royston, M.D., Founding Managing Partner, Forward Ventures "Changing Dynamics of Biotech Start-Ups" 5. Srinivas Akkaraju, M.D., Ph.D., Managing Director, Panorama Capital "A Fundamentals-Based Approach to Deriving a Biotech Investment Thesis" 6. Dion Madsen and Andrew Williamson, Managing Director and Director, Physic Ventures "Investing in Consumer-Directed Health: A New Opportunity for Venture Capital Investment" 7. Dennis J. Purcell, Senior Managing Director, Aisling Capital LLC "Responding to Trends in Biotech Investments" 8. Stuart Page, CEO, Glori Oil "Funding and Growing a Biotechnology Company in the Energy Space" 9. John Melo, CEO, Amyris "Raising Venture Capital Funding in the Industrial Biotech Sector" 10. Edward R. Teitel, M.D., President and CEO, ThromboVision Inc. "Launching a VC-Backed Life Science Company" 11. David Wellis, Ph.D., President and CEO, GenVault Corporation "A Practical Perspective on Growing and Funding a Life Science Company" 12. Thomas van Haarlem, M.D., President and CEO, Aerie Pharmaceuticals "Successful Fundraising Strategies for Early-Stage Biotech Companies"